Ternalys Therapeutics, Inc.

Overview

The simultaneous delivery of multiple microRNAs using Ternalys’ proprietary SAGUARO platform overcomes the problem of tumor resistance

Classification

This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.

1. Manufacturing32
2. Chemical Manufacturing325
3. Pharmaceutical and Medicine Manufacturing32541
4. Pharmaceutical Preparation Manufacturing325412

Capabilities